BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Dimethyl fumarate (Skilarence) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Dimethyl fumarate (Skilarence)\, from Cli
 nicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06513533-1887@assetmemo.bio
DTSTAMP:20261121T010011Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Dimethyl fumarate (Skilarence): Phase 2/3 readout est. (NCT06513533
 )
DESCRIPTION:Dimethyl fumarate (Skilarence)\, phase 2/3.\nStudy: Dimethyl Fu
 marate in Adrenomyeloneuropathy\nEstimated primary completion: 31 March 20
 28. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/dimethyl-fumarate
 -skilarence#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT06513533
URL:https://assetmemo.bio/drug/dimethyl-fumarate-skilarence#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
